Translational Software Inc. Pharmacogenomic Application Integrates Drug-Gene and Drug-Drug Data into Single Screen Interface, Replacing Paper PDF Files and Streamlining Precision Medicine

First intelligent application available via API that can be integrated into electronic health record or e-prescribing systems for real-time genomic decision support at the point of care


BELLEVUE, Wash.–(BUSINESS WIRE)–Translational Software®, Inc. (TSI), a leader in the intelligent use of genetic data for clinical decision support, today announced a new pharmacogenomic (PGx) application called Medsreview to help healthcare providers review and reconcile drug-gene and drug-drug interactions using a single screen interface to guide clinical decision making, minimize adverse reactions and enable physicians to prescribe the most effective medications in real-time.

“We were an early adopter of this technology, and integrated Medsreview into our proprietary reporting software, Clarity, to give physicians a single landing place for all of their laboratory results. Medsreview and Clarity allow a physician to greatly improve a patient’s outcome by prescribing the right medication the first time.”

Tweet this








Read More